Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)

Clinical trial NCT01395992 · COMPLETED

Trial details

NCT number: NCT01395992
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2012-04-01
Primary completion: 2014-12-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.